BlueSphere Bio
Pre-clinicalDeveloping novel TCR-based therapies to treat hematologic malignancies, solid tumors, and rare diseases. BlueSphere Bio’s vision is for every cancer patient ...
Founded
2019
Focus
Cell & Gene Therapy
About
Developing novel TCR-based therapies to treat hematologic malignancies, solid tumors, and rare diseases. BlueSphere Bio’s vision is for every cancer patient ...
Funding History
2Total raised: $30M
Series A$25MKdT VenturesSep 15, 2022
Seed$5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2019
LocationPittsburgh, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile